ANALYSIS OF ANTIBIOTICS USE IN PEDIATRIC PNEUMONIA PATIENTS AGED 3 MONTHS - 5 YEARS

Dhita Evi Aryani, Didik Hasmono, Nun Zairina, Landia Setiawan

= http://dx.doi.org/10.20473/fmi.v52i2.5224
Abstract views = 5321 times | downloads = 4645 times

Abstract


Pneumonia is an infectious disease that causes acute inflammation of the lung parenchyma and compaction exudate in the lung tissue. In addition to causing significant morbidity and mortality, pneumonia is also difficult to diagnose, treatments are less precise and less taken seriously. Pneumonia caused the death of 14% of children under five in Indonesia, with a mortality rate of 83 children per day. The difficulty of diagnosis, the selection of a less appropriate antibiotics, side effects, differences in pharmacokinetics and pharmacodynamics of the drug in infants and antibiotics resistance is to be a problem in itself. Therefore it is necessary to study the analysis of the use of antibiotics in patients with pneumonia of children aged 3 months till 5 years. The aim of this research to analyze antibiotics therapy in patients with pneumonia of children aged 3 months till 5 years. Method: an observational cohort analysis was carried out in the Pediatrics Respirology Division Dr. Soetomo Hospital Surabaya. Data was collected from February to May 2014. Patients who met the inclusion criteria were observed prospectively and the quantity and quality of antibiotics usage assessed with Gyssens category. Result: from February to May 2014 period, prospectively, the antibiotics usage quantitative evaluation used DDD/patient days shows that ampicillin 34.39DDD/100 patient days. Qualitative evaluation using Gyssens category on 75 antibiotics therapy shows that 32% considered appropriate. So, this study showed that ampicillin is most widely and qualitative analysis, only 32% of rational use of antibiotics.

Keywords


pneumonia, pediatric, antibiotics, gyssens category, DDD/100 patient days

Full Text:

PDF

References


American Heart Association (2015). Highlights of the 2015 AHA guidelines update for CPR and ECC. Available from http://eccguidelines.heart.org/wp-content/uploads/2015/10/2015-AHA-Guidelines-Highlights-English.pdf. Accessed October 14, 2014

Asih R, Aini Z, Setiawati L (2011). Risk factor of bacteremia in children with pneumonia. Indonesian Journal of Tropical and Infectious Disease 2, 34-37

Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken Jr GH, Moore MR, St Peter SD, Stockwell JA, Swason JT (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society of America. Clinical Infectious Diseases Advance (IDSA Guidelines)

Cincinnati Children Hospital Medical Center (2005). Community Acquired Pneumonia in Children 60 days through 17 years of age - Evidence-Based Care Guideline for Children with Community Acquired Pneumonia

Clinical Practice Guidelines (2009). Clinical Practice Guidelines, Department of Pulmonology, Dr Soetomo Hospital, Surabaya

Clinical Practice Guidelines (2013). Clinical Practice Guidelines, Department of Pulmonology, Dr Soetomo Hospital, Surabaya

Cunha BA (2009). Severe community-acquired pneumonia in critical care. In: Cunha BA (ed). Infectious Diseases in Critical Care Medicine, 3th ed, Florida, CRC Press, p 164-175

Finkel R, Clark MA, Cubeddu LX (2009). Principles of antimicrobial therapy. In: Harvey RA and Champe PC (eds). Lippincott’s Illustrated Re-views Pharmacology 4th ed, Philadelphia, Lippincott William & Wilkins

Grayson LM, Kucers A, Crowe S, McCarthy J, Mills J, Mouton J, Norrby R, Paterson D, Pfaller M (2010). Kucers’ The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal, and Antiviral Drugs, Volume 1, Florida, CRC Press

Health Office, Province of East Java (2010). Profil Kesehatan Provinsi Jawa Timur Tahun 2010, Surabaya

Jesenak M, Ciljakova M, Rennerova Z, Babusikova E, Banovcin P (2011). Recurrent respiratory infections in children – definition, diagnostic approach, treatment and prevention. In: MartAn-Loeches I (ed). Bronchitis, Croatia, InTech, p 119-148

Mandell LA and Wunderink R (2010). Pneumonia. In: Kasper DL and Fauci AS (eds). Harrison’s Infectious Disease, New York, McGraw-Hill Professional

Nataprawira HM, Alwi EH, Adriani N (2010). Faktor risiko morbiditas dan mortalitas pneumonia berat pada anak usia balita. Majalah Kedokteran Indonesia 60, 443-447

PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA (2011). Challenges in infant immunity: implications for responses to infection and vaccines. Nature Immunology 12, 189-194

Purniti PS, Subanada IB, Kari IK, Arhana BNP, Iswari IS, Tarini NMA (2011). Surveilan pneumokokus dan dampak pneumonia pada anak balita. Sari Pediatri 12, 359-364

Ram G and Chinen (2011). Infection and immuno-deficiency in down syndrome. Clin Exp Immunol 164, 9-16

Said M (2010). Pneumonia. In: Rahajoe NN, Suprayitno B, Setyanto DB (eds). Buku Ajar Respirologi Anak, edisi pertama, Jakarta, Badan Penerbit IDAI, p 350-364

Setiawati L, Iskandar D, Setyoningrum RA (2012). Pneumonia. Pedoman Diagnosis dan Terapi Bagian/SMF Ilmu Kesehatan Anak, Surabaya, Fakultas Kedokteran Universitas Airlangga

Setyoningrum RA and Setiawati L (2011). Profile of community acquired pneumonia in children at Soetomo hospital Surabaya in 2007-2008. Indonesian Journal of Tropical and Infectious Disease 2, 12-14


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Dhita Evi Aryani, Didik Hasmono, Nun Zairina, Landia Setiawan

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Indexed By

View My Stats

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.